ATP-Sensitive K+ Channel–Dependent Regulation of Glucagon Release and Electrical Activity by Glucose in Wild-Type and SUR1−/− Mouse α-Cells

Patch-clamp recordings and glucagon release measurements were combined to determine the role of plasma membrane ATP-sensitive K + channels (K ATP channels) in the control of glucagon secretion from mouse pancreatic α-cells. In wild-type mouse islets, glucose produced a concentration-dependent (half-maximal inhibitory concentration [IC 50 ] = 2.5 mmol/l) reduction of glucagon release. Maximum inhibition (∼50%) was attained at glucose concentrations >5 mmol/l. The sulfonylureas tolbutamide (100 μmol/l) and glibenclamide (100 nmol/l) inhibited glucagon secretion to the same extent as a maximally inhibitory concentration of glucose. In mice lacking functional K ATP channels (SUR1 −/− ), glucagon secretion in the absence of glucose was lower than that observed in wild-type islets and both glucose (0–20 mmol/l) and the sulfonylureas failed to inhibit glucagon secretion. Membrane potential recordings revealed that α-cells generate action potentials in the absence of glucose. Addition of glucose depolarized the α-cell by ∼7 mV and reduced spike height by 30% Application of tolbutamide likewise depolarized the α-cell (∼17 mV) and reduced action potential amplitude (43%). Whereas insulin secretion increased monotonically with increasing external K + concentrations (threshold 25 mmol/l), glucagon secretion was paradoxically suppressed at intermediate concentrations (5.6–15 mmol/l), and stimulation was first detectable at >25 mmol/l K + . In α-cells isolated from SUR1 −/− mice, both tolbutamide and glucose failed to produce membrane depolarization. These effects correlated with the presence of a small (0.13 nS) sulfonylurea-sensitive conductance in wild-type but not in SUR1 −/− α-cells. Recordings of the free cytoplasmic Ca 2+ concentration ([Ca 2+ ] i ) revealed that, whereas glucose lowered [Ca 2+ ] i to the same extent as application of tolbutamide, the Na + channel blocker tetrodotoxin, or the Ca 2+ channel blocker Co 2+ in wild-type α-cells, the sugar was far less effective on [Ca 2+ ] i in SUR1 −/− α-cells. We conclude that the K ATP channel is involved in the control of glucagon secretion by regulating the membrane potential in the α-cell in a way reminiscent of that previously documented in insulin-releasing β-cells. However, because α-cells possess a different complement of voltage-gated ion channels involved in action potential generation than the β-cell, moderate membrane depolarization in α-cells is associated with reduced rather than increased electrical activity and secretion.

[1]  Lena Eliasson,et al.  Capacitance measurements of exocytosis in mouse pancreatic α‐, β‐ and δ‐cells within intact islets of Langerhans , 2004, The Journal of physiology.

[2]  P. Rorsman,et al.  Glucose inhibition of glucagon secretion from rat alpha-cells is mediated by GABA released from neighboring beta-cells. , 2004, Diabetes.

[3]  F. Ashcroft,et al.  Type 2 diabetes mellitus: not quite exciting enough? , 2004, Human molecular genetics.

[4]  E. Vieira,et al.  A store-operated mechanism determines the activity of the electrically excitable glucagon-secreting pancreatic alpha-cell. , 2004, Cell calcium.

[5]  L. Eliasson,et al.  Regulated Exocytosis of GABA-containing Synaptic-like Microvesicles in Pancreatic β-cells , 2004, The Journal of general physiology.

[6]  D. Coy,et al.  Intra-islet somatostatin regulates glucagon release via type 2 somatostatin receptors in rats. , 2003, Diabetes.

[7]  C. Wollheim,et al.  Islet β-cell secretion determines glucagon release from neighbouring α-cells , 2003, Nature Cell Biology.

[8]  L. Eliasson,et al.  SUR1 Regulates PKA-independent cAMP-induced Granule Priming in Mouse Pancreatic B-cells , 2003, The Journal of general physiology.

[9]  J. Gromada,et al.  Sulfonylurea Receptor Type 1 Knock-out Mice Have Intact Feeding-stimulated Insulin Secretion despite Marked Impairment in Their Response to Glucose* , 2002, The Journal of Biological Chemistry.

[10]  P. Rorsman,et al.  Somatostatin inhibits exocytosis in rat pancreatic α‐cells by Gi2‐dependent activation of calcineurin and depriming of secretory granules , 2001, The Journal of physiology.

[11]  Jochen Roeper,et al.  ATP-sensitive K+ channels in the hypothalamus are essential for the maintenance of glucose homeostasis , 2001, Nature Neuroscience.

[12]  P. Rorsman,et al.  Regulation of glucagon release in mouse α‐cells by KATP channels and inactivation of TTX‐sensitive Na+ channels , 2000, The Journal of physiology.

[13]  J. Henquin,et al.  Triggering and amplifying pathways of regulation of insulin secretion by glucose. , 2000, Diabetes.

[14]  P. Rorsman,et al.  Patch‐clamp characterisation of somatostatin‐secreting δ‐cells in intact mouse pancreatic islets , 2000, The Journal of physiology.

[15]  L. Eliasson,et al.  Tight coupling between electrical activity and exocytosis in mouse glucagon-secreting alpha-cells. , 2000, Diabetes.

[16]  B. Soria,et al.  Different effects of tolbutamide and diazoxide in alpha, beta-, and delta-cells within intact islets of Langerhans. , 1999, Diabetes.

[17]  U. Adamson,et al.  Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes. , 1999, The Journal of clinical endocrinology and metabolism.

[18]  S. Seino,et al.  Immuno-localization of sulphonylurea receptor 1 in rat pancreas , 1999, Diabetologia.

[19]  P. Rorsman,et al.  Characterisation of sulphonylurea and ATP-regulated K+ channels in rat pancreatic A-cells , 1999, Pflügers Archiv.

[20]  R. Rizza,et al.  Impact of lack of suppression of glucagon on glucose tolerance in humans. , 1999, American journal of physiology. Endocrinology and metabolism.

[21]  Y. Horio,et al.  Somatostatin induces hyperpolarization in pancreatic islet α cells by activating a G protein‐gated K+ channel , 1999, FEBS letters.

[22]  D. Pipeleers,et al.  The Changes in Adenine Nucleotides Measured in Glucose-stimulated Rodent Islets Occur in β Cells but Not in α Cells and Are Also Observed in Human Islets* , 1998, The Journal of Biological Chemistry.

[23]  J. Miyazaki,et al.  Defective insulin secretion and enhanced insulin action in KATP channel-deficient mice. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[24]  I. Lundquist,et al.  The Nitric Oxide Synthase Inhibitor NG-nitro-L-Arginine Methyl Ester Potentiates Insulin Secretion Stimulated by Glucose and L-Arginine Independently of its Action on ATP-Sensitive K+ Channels , 1998, Bioscience reports.

[25]  P. Rorsman,et al.  Adrenaline Stimulates Glucagon Secretion in Pancreatic A-Cells by Increasing the Ca2+ Current and the Number of Granules Close to the L-Type Ca2+ Channels , 1997, The Journal of general physiology.

[26]  S. Dinneen,et al.  The Postprandial State: Mechanisms of Glucose Intolerance , 1997, Diabetic medicine : a journal of the British Diabetic Association.

[27]  O. Madsen,et al.  The glucose sensor protein glucokinase is expressed in glucagon-producing alpha-cells. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[28]  D. Pipeleers,et al.  Differences in Glucose Transporter Gene Expression between Rat Pancreatic α- and β-Cells Are Correlated to Differences in Glucose Transport but Not in Glucose Utilization (*) , 1995, The Journal of Biological Chemistry.

[29]  A. Berts,et al.  Ca2+ oscillations in pancreatic islet cells secreting glucagon and somatostatin. , 1995, Biochemical and biophysical research communications.

[30]  C. Buettger,et al.  Sulfonylurea-Binding Sites and ATP-Sensitive K+ Channels in α-TC Glucagonoma and β-TC Insulinoma Cells , 1993, Diabetes.

[31]  M. Erecińska,et al.  GABA in pancreatic islets: metabolism and function. , 1992, Biochemical pharmacology.

[32]  R. Rizza,et al.  Contribution to Postprandial Hyperglycemia and Effect on Initial Splanchnic Glucose Clearance of Hepatic Glucose Cycling in Glucose-Intolerant or NIDDM Patients , 1991, Diabetes.

[33]  P. Rorsman,et al.  Glucose-inhibition of glucagon secretion involves activation of GABAA-receptor chloride channels , 1989, Nature.

[34]  P. Rorsman,et al.  Two types of Ca2+ currents with different sensitivities to organic Ca2+ channel antagonists in guinea pig pancreatic alpha 2 cells , 1988, The Journal of general physiology.

[35]  P. Rorsman,et al.  Voltage-activated currents in guinea pig pancreatic alpha 2 cells. Evidence for Ca2+-dependent action potentials , 1988, The Journal of general physiology.

[36]  V. Grill,et al.  Sulfonylurea-induced inhibition of glucagon secretion from the perfused rat pancreas: evidence for a direct, non-paracrine effect , 1986, Diabetologia.

[37]  R. Unger,et al.  Glucagon physiology and pathophysiology in the light of new advances , 1985, Diabetologia.

[38]  J. Halter,et al.  Suppression of glucagon secretion during a tolbutamide infusion in normal and noninsulin-dependent diabetic subjects. , 1983, The Journal of clinical endocrinology and metabolism.

[39]  P. Lefèbvre,et al.  Glucagon and diabetes: A reappraisal , 1979, Diabetologia.

[40]  L. Orci,et al.  The role of glucagon in diabetes. , 1977, Comprehensive therapy.

[41]  S. Christensen,et al.  Thapsigargin, a novel molecular probe for studying intracellular calcium release and storage , 2005, Agents and Actions.

[42]  T. Jenssen,et al.  Contribution of abnormal muscle and liver glucose metabolism to postprandial hyperglycemia in NIDDM. , 1990, Diabetes.

[43]  F. Ashcroft,et al.  Electrophysiology of the pancreatic beta-cell. , 1989, Progress in biophysics and molecular biology.